Scott+Scott Attorneys at Law LLP Announces Investigation into Intercept Pharmaceuticals, Inc. (ICPT)PRNewsWire • 10/30/20
The Law Offices of Frank R. Cruz Announces Investigation of Intercept Pharmaceuticals, Inc. (ICPT) on Behalf of InvestorsBusiness Wire • 10/29/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Intercept Pharmaceuticals, Inc. (ICPT) on Behalf of InvestorsBusiness Wire • 10/29/20
New PBC and NASH Data to be Presented at AASLD's The Liver Meeting Digital Experience™GlobeNewsWire • 10/29/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Intercept Pharmaceuticals, Inc. (ICPT) on Behalf of InvestorsBusiness Wire • 10/29/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 10/22/20
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Intercept Pharmaceuticals, Inc. – ICPTBusiness Wire • 10/22/20
Intercept (ICPT) Down 16.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/09/20
New Data from the Interim Analysis of REGENERATE Show that OCA Helped Patients with Liver Fibrosis Due to NASH Achieve Sustained Improvement in Noninvasive Markers of Fibrosis Over Two Years of TreatmentGlobeNewsWire • 08/27/20
Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2020GlobeNewsWire • 08/21/20
Intercept Pharmaceuticals Reports Second Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business UpdateGlobeNewsWire • 08/10/20
Intercept to Announce Second Quarter 2020 Financial Results on August 10, 2020GlobeNewsWire • 08/03/20